FORE-SIGHT Tissue Oximeter During Cardiac Surgery (FORE-SIGHT)
CAS Medical Systems FORE-SIGHT Elite Tissue Oximeter During Cardiac Surgery
Sponsor: CAS Medical Systems, Inc.
This observational or N/A phase trial investigates Cardiac Surgical Patients and is currently completed. CAS Medical Systems, Inc. leads this study, which shows 10 recorded versions since 2014 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Dec 2020 — Jan 2021 [monthly]
Completed
Status: Recruiting → Completed
-
Nov 2019 — Dec 2020 [monthly]
Recruiting
▶ Show 5 earlier versions
-
Jul 2018 — Nov 2019 [monthly]
Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Feb 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
May 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CAS Medical Systems, Inc.
- University of California, Los Angeles
For direct contact, visit the study record on ClinicalTrials.gov .